RESUMO
Introducción. El trasplante es una de las alternativas para el tratamiento de enfermedades neurodegenerativas, y está encaminado hacia el reemplazo de las células perdidas durante el desarrollo de la enfermedad. Una fuente celular prometedora para el desarrollo de los trasplantes podrían ser las células mononucleadas de la médula ósea. Objetivo. Estudiar la capacidad de las células mononucleadas de la médula ósea de sobrevivir al trasplante y buscar un método que permita el seguimiento de estas células in vivo una vez implantadas. Materiales y métodos. Las células mononucleadas fueron extraídas del fémur de ratas mediante un gradiente de Ficoll-Hypaque. Las células objeto de estudio fueron modificadas genéticamente con un adenovirus que expresa la PFV o marcadas con el reactivo de Hoechst. Las células marcadas se implantaron en el estriado de ratas lesionadas con ácido quinolínico. Resultados. La viabilidad de las células modificadas genéticamente fue baja, mientras que la de las células marcadas con el reactivo de Hoechst fue superior al 90 por ciento. Las células implantadas sobrevivieron al trasplante al menos un mes y se dispersaron desde el sitio de entrada hacia el cuerpo calloso y la corteza. Conclusiones. Consideramos más ventajoso el uso del reactivo de Hoechst para el seguimiento de estas células in vivo. Las células mononucleadas tienen características que les permiten formar parte de las fuentes celulares candidatas para el tratamiento de las enfermedades neurodegenerativas(AU)
Introduction: Transplant is one of the alternatives available for the treatment of neurodegenerative diseases aimed at replacing the cells lost during the course of the disease. One promising source of cells for the development of transplants could be the mononucleate cells from bone marrow. AIMS. The purpose of this study was to study the capacity of bone marrow mononucleate cells to survive the transplant process, and to search for a method that enables tracking of these cells in vivo once they have been implanted. MATERIALS AND METHODS: Bone marrow mononucleate cells were extracted from the femur of rats by means of a Ficoll-Hypaque gradient. The cells under study were modified genetically with an adenovirus that expresses the PFV or which are marked with Hoechst dye. The marked cells were implanted in the striatum of rats with lesions caused by quinolinic acid. RESULTS: The viability of the genetically modified cells was low, whereas that of the cells marked with Hoechst dye was above 90percent. The implanted cells survived the transplant at least a month and dispersed away from the site of entry towards the corpus callosum and cortex. CONCLUSIONS: We consider that the use of Hoechst dye offers more advantages for tracking these cells in vivo. Mononucleate cells have a number of characteristics that allow them to be included as candidate sources of cells for the treatment of neurodegenerative diseases
Assuntos
Animais , Ratos , Células da Medula Óssea/citologia , Células da Medula Óssea/fisiologia , Transplante de Medula Óssea , Movimento Celular , Ácido Quinolínico/toxicidade , Córtex Visual/citologia , Córtex Visual , Córtex Visual/patologiaRESUMO
INTRODUCTION: Transplant is one of the alternatives available for the treatment of neurodegenerative diseases aimed at replacing the cells lost during the course of the disease. One promising source of cells for the development of transplants could be the mononucleate cells from bone marrow. AIMS. The purpose of this study was to study the capacity of bone marrow mononucleate cells to survive the transplant process, and to search for a method that enables tracking of these cells in vivo once they have been implanted. MATERIALS AND METHODS: Bone marrow mononucleate cells were extracted from the femur of rats by means of a Ficoll-Hypaque gradient. The cells under study were modified genetically with an adenovirus that expresses the PFV or which are marked with Hoechst dye. The marked cells were implanted in the striatum of rats with lesions caused by quinolinic acid. RESULTS: The viability of the genetically modified cells was low, whereas that of the cells marked with Hoechst dye was above 90%. The implanted cells survived the transplant at least a month and dispersed away from the site of entry towards the corpus callosum and cortex. CONCLUSIONS: We consider that the use of Hoechst dye offers more advantages for tracking these cells in vivo. Mononucleate cells have a number of characteristics that allow them to be included as candidate sources of cells for the treatment of neurodegenerative diseases.
Assuntos
Células da Medula Óssea , Transplante de Medula Óssea , Sobrevivência Celular , Ácido Quinolínico/toxicidade , Córtex Visual , Animais , Benzimidazóis/metabolismo , Células da Medula Óssea/citologia , Células da Medula Óssea/fisiologia , Movimento Celular , Corantes Fluorescentes/metabolismo , Masculino , Doenças Neurodegenerativas/terapia , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley , Córtex Visual/citologia , Córtex Visual/efeitos dos fármacos , Córtex Visual/patologiaRESUMO
INTRODUCTION: A good deal of evidence currently exists to show that transplanting foetal mesencephalic tissue can produce symptomatic benefits both in patients and in disease models. Nevertheless, the technical and ethical difficulties involved in obtaining enough suitable foetal cerebral tissue have been a serious obstacle to its application. Stromal cells derived from bone marrow, due to their potential capacity to generate different types of cells, could be an ideal source of material for cell restoration in neurodegenerative diseases. AIMS: Our aim was to evaluate the effect of transplanting stromal cells derived from bone marrow on the behaviour of 6-OHDA rats, when they are inserted into the striatum. MATERIAL AND METHODS: In this study we used rats with a lesion in the substantia nigra induced by 6-hydroxydopamine, divided into several experimental groups. Rotary activity induced by D-amphetamine (5 mg/kg, intraperitoneally) was evaluated before and throughout the three months following the transplant in all the experimental groups, except in the group of healthy controls. Hemiparkinsonian rats received a total of 350 000 foetal ventral mesencephalic cells and 8 x 10(4) stromal cells/microL, which were implanted in the striatum. RESULTS AND CONCLUSIONS: Animals with stromal cells transplanted in the body of the striatum significantly reduced the number of turns induced by amphetamine (p < 0.05); yet this reduction was not greater than that induced by foetal mesencephalic cell transplants. We were also unable to demonstrate any significant improvement in the motor skills of the forelimbs.
Assuntos
Modelos Animais de Doenças , Doença de Parkinson/cirurgia , Células Estromais/transplante , Animais , Comportamento Animal , Masculino , Oxidopamina/administração & dosagem , Doença de Parkinson/etiologia , Ratos , Ratos WistarRESUMO
A good deal of evidence currently exists to show that transplanting foetal mesencephalic tissue can produce symptomatic benefits both in patients and in disease models. Nevertheless, the technical and ethical difficulties involved in obtaining enough suitable foetal cerebral tissue have been a serious obstacle to its application. Stromal cells derived from bone marrow, due to their potential capacity to generate different types of cells, could be an ideal source of material for cell restoration in neurodegenerative diseases. AIMS: Our aim was to evaluate the effect of transplanting stromal cells derived from bone marrow on the behaviour of 6-OHDA rats, when they are inserted into the striatum(AU)
Assuntos
Animais , Ratos , Modelos Animais de Doenças , Doença de Parkinson/cirurgia , Células Estromais/transplanteRESUMO
AIMS: The aim of this study is to describe the capacity of bone marrow cells to limit or slow down the damage and chronic neuronal degeneration produced by degenerative diseases of the central nervous system (CNS), as well as the potential capacity of the method to provide other substances or genetic material. DEVELOPMENT: The search for new sources of cells that maintain the ability to divide and distinguish themselves from different cellular phenotypes opens up huge new opportunities in the restorative therapy of these clinical entities. Bone marrow cells, and especially stromal stem cells, have been seen to conserve a high capacity to distinguish and originate different strains of characteristic brain cells (neurons, astrocytes, and glial cells), and also the capacity to restore the population of stem cells when they are stimulated in a suitable fashion. CONCLUSIONS: Future experimental studies will be aimed at searching for new ways to enhance the composition, viability and differentiation of the cells to be implanted and will evaluate their effects on diseases of the CNS.
Assuntos
Células da Medula Óssea/metabolismo , Doenças do Sistema Nervoso Central/terapia , Doenças Neurodegenerativas/terapia , Transplante de Células-Tronco , Células Estromais/metabolismo , Animais , Células da Medula Óssea/citologia , Humanos , Fatores de Crescimento Neural/metabolismo , Fenótipo , Células Estromais/citologiaRESUMO
OBJECTIVE: Taking into account the growing development and application of in vivo and ex vivo gene therapy in neurodegenerative disorders we review this kind of therapy applications in Parkinson s disease. DEVELOPMENT: Gene therapy carried out to this illness includes the liberation of genes encoding biosynthetic enzymes for dopamine synthesis: tyrosine hydroxylase, AADC and GTP cyclohydrolase and neurotrophic factors like GDNF which promotes the survival and maintenance of dopamin rgic neurons. Ex vivo gene therapy allows the control of the gene transfer before implantation, however one of the fundamental problems of this procedure is given by the immunologic rejection, so the use of autologous sources is recommended. CONCLUSIONS: Ex vivo gene therapy is advantageous in relation to in vivo gene therapy because it allows the control of gene transfer before the implantation; looking for cellular sources of neural origin or pluripotent stem cells which can be differenciated toward a wanted cellular type in order to achieve the structural and functional integration of the cells implanted in the central nervous system are recommended; however it becomes necessary the development of vectors of new generation to avoid biosafety problems involved in the gene therapy.